Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. (Q45956350)
Jump to navigation
Jump to search
scientific article published on 23 June 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. |
scientific article published on 23 June 2009 |
Statements
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer (English)
H Hellborg
U Johansson
G Elmberger
L Skoog